February 26, 2018 / 4:09 PM / 3 months ago

BRIEF-Merck KGaA Says Cladribine Tablets Win First Approval In Latin America‍​

Feb 26 (Reuters) - Merck KGaA:

* SAYS MAVENCLAD (CLADRIBINE TABLETS) RECEIVES FIRST APPROVAL IN LATIN AMERICA‍​

* ARGENTINA'S ANMAT HAS APPROVED REGISTRATION OF CLADRIBINE TABLETS FOR THE TREATMENT OF ADULT PATIENTS WITH HIGHLY ACTIVE RELAPSING MULTIPLE SCLEROSIS Source text: here Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below